Your session is about to expire
← Back to Search
Other
Tart Cherry + Fish Oil for Joint Pain
Phase < 1
Waitlist Available
Led By Philip Chang, DO
Research Sponsored by Philip Chang
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Currently receiving AI therapy
Breast cancer diagnosis (Stage I-III) with any hormonal status
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial tests if taking tart cherry & fish oil together can help reduce joint stiffness & other health issues in an obese breast cancer population.
Who is the study for?
This trial is for women over 18 with breast cancer stages I-III, currently on AI therapy, BMI ≥ 27, and experiencing joint pain from the treatment. They must have an Omega-3 Index <8%, a clinical diagnosis of AIMSS, and a certain level of joint pain. Excluded are those with stroke history, anticoagulant use, cherry or fish allergies, inflammatory joint diseases, recent changes in pain medication use or steroid use.Check my eligibility
What is being tested?
The study tests if Tart Cherry concentrate combined with fish oil can reduce arthritis symptoms in obese breast cancer patients suffering from AIMSS during a 12-week period compared to a control group. It also looks at secondary outcomes like pain relief and quality of life improvements.See study design
What are the potential side effects?
Tart Cherry and Omega-3 supplements generally have fewer side effects than other medications for AIMSS such as NSAIDs or steroids. Possible mild side effects may include digestive discomfort or allergic reactions for those sensitive to cherries or fish.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am currently on aromatase inhibitor therapy.
Select...
I have been diagnosed with Stage I-III breast cancer.
Select...
I have been diagnosed with AIMSS.
Select...
My average joint pain score is 4 or higher.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The primary objective is to assess changes in arthritis symptoms between groups.
Secondary outcome measures
To assess changes in cognition between groups.
To assess changes in functional performance between groups.
To assess changes in nociplastic pain between groups.
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Group 2 : Tart Cherry and Omega 3 FA (Fish Oil)Experimental Treatment2 Interventions
Group II: Group 1 : Wait list controlActive Control1 Intervention
No supplement but will be offered supplements after finishing the study
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tart Cherry
2023
Completed Phase 2
~80
Find a Location
Who is running the clinical trial?
The Cherry Marketing InstituteUNKNOWN
Philip ChangLead Sponsor
Philip Chang, DOPrincipal InvestigatorCedars-Sinai Medical Center
1 Previous Clinical Trials
16 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are new participants still signing up for this research project?
"As noted on clinicaltrials.gov, the trial posted on January 1st 2024 is not currently recruiting patients. The last update was made in November 7th 2023. Nevertheless, there are still 1539 trials actively enlisting new participants at this time."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger